News

Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of ...
The Indian QR coding programme introduced in 2023 to detect counterfeit medicines will instead now cause great harm.
Orthopedic surgeons were found to receive the largest total sum of payments The top drugs related to industry payments were blood thinners Xarelto & Eliquis READ MORE: Big pharma has hiked prices of ...
The United States and New Zealand are the only countries that allow this type of advertising. None of this was legal until 1997 when the FDA authorized it. Perhaps it is not surprising that the FDA ...
Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The ...
On top of noninferior efficacy, the trial showed patients had less bleeding with 2.5 mg vs 5.0 mg twice daily over 12 months.
The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due to the better-than-expected fourth-quarter performance of large ...
A new study has discovered what researchers say is the first drug to fully reproduce the effects of physical stroke rehabilitation in model mice, following from human studies. A new study by UCLA ...
The drug, tested on mice, restored these gamma oscillations, and in turn reconnected neurons to essentially heal the brain damage without arduous physical rehabilitation.
Banjul, The Gambia – On a humid March afternoon on the outskirts of Banjul, a woman known only as Saf* carries a basket of plants from her garden. Moving with urgency to avoid prying eyes, she ...
March 18 (Reuters) - Widely used prescription medicines could get caught up in the Trump administration's tariff trade wars and EU retaliation. The following is a list of major prescription drugs ...
New data from the Phase II RAINFOL-01 study shows rinatabart sesutecan (Rina-S), an investigative antibody-drug conjugate, demonstrated a confirmed objective response rate of 55.6%. Genmab has shared ...